PT - JOURNAL ARTICLE AU - Greene, Sharon K. AU - Tabaei, Bahman P. AU - Culp, Gretchen M. AU - Levin-Rector, Alison AU - Kishore, Nishant AU - Baumgartner, Jennifer TI - Effects of return-to-office, public schools reopening, and vaccination mandates on COVID-19 cases among municipal employee residents of New York City AID - 10.1101/2022.10.17.22280652 DP - 2022 Jan 01 TA - medRxiv PG - 2022.10.17.22280652 4099 - http://medrxiv.org/content/early/2022/10/19/2022.10.17.22280652.short 4100 - http://medrxiv.org/content/early/2022/10/19/2022.10.17.22280652.full AB - Objective On September 13, 2021, teleworking ended for New York City municipal employees, and Department of Education (DOE) employees returned to reopened schools. On October 29, COVID-19 vaccination was mandated. We assessed these mandates’ short-term effects on disease transmission.Methods Using difference-in-difference analyses, we calculated COVID-19 incidence rate ratios (IRR) among residents 18–64 years-old by employment status pre- and post-policy implementation.Results IRRs post-(September 23–October 28) vs. pre-(July 5–September 12) return-to-office were similar between office-based City employees and non-City employees. Among DOE employees, the IRR after schools reopened was elevated 28.4% (95% CI: 17.3%–40.3%). Among City employees, the IRR post-(October 29–November 30) vs. pre- (September 23– October 28) vaccination mandate was lowered 20.1% (95% CI: 13.7%–26.0%).Conclusions Workforce mandates influenced disease transmission, among other societal effects.Competing Interest StatementA subset of authors (Dr. Greene, Mr. Tabaei, Dr. Culp, and Ms. Baumgartner) are City of New York employees and were subject to mandates assessed in this analysis. The authors report no other conflicts of interest.Funding StatementThe authors received no specific funding for this work beyond their usual salaries. Dr. Greene was supported by the Public Health Emergency Preparedness Cooperative Agreement (grant No. NU90TP922035-03-03), funded by the US Centers for Disease Control and Prevention.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the New York City Department of Health and Mental Hygiene gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesLine-level data are not publicly available in accordance with patient confidentiality and privacy laws. Publicly available data are linked below. https://www1.nyc.gov/site/doh/covid/covid-19-data.page (CDC)U.S. Centers for Disease Control and Prevention(CI)confidence interval(DCAS)Department of Citywide Administrative Services(DOHMH)Department of Health and Mental Hygiene(NYC)New York City(UHF)United Hospital Fund